Skip 
Navigation Link

1215 South Walnut Ave.
Demopolis, AL 36732 map map 

Access to Care: 1-800-239-2901




1215 South Walnut Ave.
Demopolis, AL 36732
334.289.2410 
334.289.2416 (fax)


powered by centersite dot net
Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
AHA News: These 'Concrete Steps' Could Help Fight Racism in Health CareFear of Losing Health Insurance Keeps 1 in 6 U.S. Workers in Their JobsWhen Drug Companies Raise Prices, Patients' Out-of-Pocket Costs RiseMost Top U.S. Surgeons Are White and That's Not ChangingAmericans Missed Almost 10 Million Cancer Screenings During PandemicU.S. Birth Rates Continue to FallBiden Sets New Goal of Vaccinating 70% of Americans by July 41 in 3 Neighborhoods in Major U.S. Cities Is a 'Pharmacy Desert'You Got Your COVID Shot: What to Do With That Vaccine CardFinding a Doctor Is Tough and Getting Tougher in Rural AmericaUrgent Care or the ER? Which Should You Choose?FDA Poised to Ban Menthol CigarettesPoll Reveals Who's Most Vaccine-Hesitant in America and WhyAHA News: Food, Culture and the Secret Ingredient to Address Lack of Diversity in Nutrition FieldCDC Decision on Johnson & Johnson Vaccine Pause Expected FridayAHA News: How to Make Sure Everyone Gets a Fair Shot at the COVID-19 VaccineLittle Progress in Boosting Numbers of Black American DoctorsHigh-Profile Police Brutality Cases Harm Black Americans' Mental Health: StudyAHA News: Could the Pandemic Help Boost Diversity in Clinical Trials?Americans Still Avoiding ERs in Pandemic, But Uptick Seen in Mental Health CrisesCDC Panel Says It Needs More Time to Study J&J Vaccine Clotting CasesAHA News: 5 Things to Know This Earth Day About How the Environment Affects Health4 in 10 Adults Over 50 Consult Online Reviews When Picking a DoctorCBD or THC? Cannabis Product Labels Often Mislead, Study FindsPandemic Has Put Many Clinical Trials on HoldDespite Pandemic's Toll, Many Older Adults Don't Have Living Wills'Heart-in-a-Box' Can Be Lifesaving, Matching Up Distant Donors With PatientsPublic Lost Trust in CDC During COVID Crisis: PollNearly 8 in 10 School, Child Care Staff Have Gotten at Least 1 Dose of COVID Vaccine: CDCWhy Are ER Wait Times Getting Longer for Kids in Mental Health Crisis?Buying Your Own Health Insurance Just Got Way Less ExpensiveStrain of COVID Care Has Many Health Professionals Looking for an ExitBlack Americans Often Face Discrimination in Health CareHow Willing Are Americans to Donate COVID Vaccines to Other Countries?Too Few Minorities in U.S. Health Care Workforce: ReportBlack Patients Often Treated at Hospitals With Poorer Safety Records: ReportDon't Delay Your Cancer Screenings, Surgeons' Group UrgesBiden Administration Working on 'Vaccine Passport' InitiativeStates Race to Vaccinate Their ResidentsFDA Clamping Down on Abuse of an OTC  DecongestantShortage of Primary Care Doctors Is Costing American LivesStudy Finds Growing Acceptance of COVID Vaccine by U.S. Health Care Workers'Avoidable Hospitalizations:' Another Way the Pandemic Is Tougher on MinoritiesOn-the-Road Help: 'Mobile Stroke Units' Are Saving People's LivesTalks With Doctors May Be Key to Vaccine Acceptance: StudyAs U.S. Vaccinations Rise, Are 'Vaccine Passports' for Americans Coming?Begin Routine Diabetes Screening at 35 for Overweight, Obese Americans: Task Force'Race Gap' in U.S. Heart Health Has Changed Little in 20 Years: ReportDriven by Anti-Vaxxers, Measles Outbreaks Cost Everyone MoneyScams Await Many Americans Desperate to Get COVID Vaccine
Questions and AnswersVideosLinksBook Reviews
Related Topics

Health Insurance
Healthcare

FDA Clamping Down on Abuse of an OTC  Decongestant

HealthDay News
by By Robert Preidt HealthDay Reporter
Updated: Mar 25th 2021

new article illustration

THURSDAY, March 25, 2021 (HealthDay News) -- Makers of inhalers that contain the nasal decongestant propylhexedrine should make design changes to prevent misuse, the U.S. Food and Drug Administration says.

Propylhexedrine is a nasal decongestant in over-the-counter inhalers, and right now is "only marketed under the brand name Benzedrex," the FDA said. The agency said that propylhexedrine is effective and safe when used for short periods as directed for relief of congestion due to colds, hay fever or other upper respiratory allergies. But misuse can bring dangers.

"Benzedrex inhalers can be legally purchased, but propylhexedrine abuse occurs as people try to find legal ways to get high or increase productivity and concentration," according to the National Capital Poison Center (NCPC).

"There have been many reports of toxicity associated with propylhexedrine extracted from an inhaler and swallowed or injected. Swallowing the contents of one propylhexedrine inhaler has caused heart attack and lung injury in adults and children," the NCPC added.

The FDA warns that reports of abuse and misuse of propylhexedrine have been on the rise. The drug can lead to serious problems -- including fast or abnormal heart rhythm, high blood pressure and paranoia -- that can result in hospitalization, disability or death.

"We are requesting that all manufacturers of [over-the-counter] propylhexedrine nasal decongestant inhalers consider product design changes that support its safe use," the FDA said in a news release.

"For example, modifying the product to create a physical barrier that would make tampering with the device and abusing the propylhexedrine inside more difficult," the agency said.

Reducing the amount of propylhexedrine in inhalers could also lower the risk of serious side effects, the FDA noted.

"We continue to evaluate this safety issue and will determine if additional FDA actions are needed," the agency said.

Propylhexedrine was developed over 60 years ago as a substitute for amphetamine, once the active ingredient in Benzedrex inhalers, according to the NCPC. The center noted that the change was made in response to abuse and deaths from amphetamine extracted from the inhalers.

Propylhexedrine reduces swelling and inflammation of the nasal lining. The recommended dose for adults and kids over 6 is two puffs in each nostril, not more often than every two hours. It shouldn't be used for more than three days at a time.

Prolonged use may cause congestion to recur or worsen.

The FDA urged people to call 911 or poison control at 800-222-1222 if someone using propylhexedrine experiences severe anxiety or agitation, confusion, hallucinations or paranoia, rapid heartbeat or abnormal heart rhythm, chest pain or tightness.

If you have questions about the drug, including how to use it or whether it may interact with another medicine you take, talk to a pharmacist or your health care provider, the FDA urged.

More information

The Laguna Treatment Hospital has more on propylhexedrine abuse.


SOURCE: U.S. Food and Drug Administration, news release, March 25, 2021